You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 24, 2025

Drug Price Trends for NYSTATIN-TRIAMCINOLONE CREAM


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for NYSTATIN-TRIAMCINOLONE CREAM

Average Pharmacy Cost for NYSTATIN-TRIAMCINOLONE CREAM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NYSTATIN-TRIAMCINOLONE CREAM 45802-0880-14 0.43991 GM 2025-03-19
NYSTATIN-TRIAMCINOLONE CREAM 33342-0482-30 0.33122 GM 2025-03-19
NYSTATIN-TRIAMCINOLONE CREAM 33342-0482-60 0.24883 GM 2025-03-19
NYSTATIN-TRIAMCINOLONE CREAM 45802-0880-94 0.33122 GM 2025-03-19
NYSTATIN-TRIAMCINOLONE CREAM 33342-0482-15 0.43991 GM 2025-03-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Nystatin-Triamcinolone Cream

Introduction to Nystatin-Triamcinolone Cream

Nystatin-triamcinolone cream is a topical medication that combines the antifungal properties of nystatin with the anti-inflammatory and immunosuppressive properties of triamcinolone. This combination is commonly used to treat cutaneous candidiasis and other skin conditions characterized by fungal infections and inflammation.

Market Size and Growth

The triamcinolone market, which includes nystatin-triamcinolone cream, was valued at approximately USD 0.9 billion in 2023 and is projected to reach USD 1.3 billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 3.8% from 2024 to 2033[4].

Segment Analysis

By Type

The cream segment dominates the triamcinolone market, including nystatin-triamcinolone cream, due to its convenient and non-invasive method of application. This segment is expected to continue growing at a CAGR of 3.6% over the coming years[1][4].

By Application

The eczema segment, which includes treatments for atopic dermatitis, is a significant driver of the market. Eczema affects a substantial portion of the global population, leading to consistent demand for effective treatments like nystatin-triamcinolone cream. This segment is expected to register the fastest growth during the forecast period[4].

By Distribution Channel

Drug stores are the primary distribution channel for nystatin-triamcinolone cream, accounting for a significant market share. The accessibility and convenience of drug stores make them a preferred point of purchase for patients, contributing to the segment's growth[4].

Regional Outlook

North America

The North American market, particularly the United States, is robust due to the high prevalence of chronic diseases such as arthritis, asthma, and dermatological conditions. The advanced healthcare infrastructure and widespread availability of triamcinolone products, including nystatin-triamcinolone cream, contribute to its strong market presence in this region[4].

Europe

Europe also shows substantial market growth, driven by a well-established healthcare system and increasing incidence of autoimmune and inflammatory diseases. Countries like Germany, France, and the UK are key markets within Europe, benefiting from high levels of healthcare access and a growing aging population[4].

Asia-Pacific

The Asia-Pacific region is experiencing rapid expansion in the triamcinolone market, fueled by increasing healthcare awareness, rising prevalence of chronic conditions, and improving healthcare infrastructure in countries like China, India, and Japan. The large population base and growing middle class in these countries drive demand for effective and accessible treatments like nystatin-triamcinolone cream[4].

Price Projections

Current Pricing

The cost for nystatin-triamcinolone topical cream can range from $30.87 to $31.75 for a 15-gram supply, depending on the pharmacy and location. For a 15-gram supply of the topical ointment, prices range from $25.41 to $31.17[2].

Future Pricing Trends

Given the projected market growth, prices may remain relatively stable or see moderate increases due to factors such as inflation, regulatory changes, and advancements in formulation. However, the availability of generic versions and patient assistance programs can help mitigate cost increases for consumers[5].

Drivers and Opportunities

Broad Therapeutic Applications

The anti-inflammatory and immunosuppressive properties of triamcinolone make it a valuable treatment for various dermatological and respiratory conditions, driving consistent demand for nystatin-triamcinolone cream[4].

Rise in Geriatric Population

The aging population is more susceptible to severe allergic reactions, eye conditions, and chronic diseases, which increases the demand for triamcinolone-based treatments[4].

Development of Healthcare Infrastructure

Improving healthcare infrastructure in developing countries is expected to increase access to triamcinolone products, including nystatin-triamcinolone cream, thereby driving market growth[4].

Restraints and Challenges

Side Effects and Long-term Use Risks

The long-term use of triamcinolone can lead to side effects such as skin thinning, telangiectasia, and adrenal suppression, which can restrain market growth. However, advancements in formulation and delivery systems aim to mitigate these risks[4].

Key Players

The market for nystatin-triamcinolone cream is highly competitive, with prominent players including Akorn Inc., Bristol Myers Squibb Company, and Cosette Pharmaceuticals, Inc. These companies are involved in research and development to improve formulations and delivery systems, which can enhance market share[4].

Patient Assistance and Savings

To make nystatin-triamcinolone cream more affordable, various patient assistance programs, coupons, and savings cards are available. These programs can help patients save up to 90% on their medication costs, making the treatment more accessible[5].

Key Takeaways

  • The triamcinolone market, including nystatin-triamcinolone cream, is projected to grow at a CAGR of 3.8% from 2024 to 2033.
  • The cream segment dominates the market due to its convenience and effectiveness.
  • Eczema and other dermatological conditions drive the demand for nystatin-triamcinolone cream.
  • North America, Europe, and the Asia-Pacific region are key markets due to their healthcare infrastructure and population demographics.
  • Patient assistance programs and generic versions help in reducing the cost burden on consumers.

FAQs

What is the primary use of nystatin-triamcinolone cream?

Nystatin-triamcinolone cream is primarily used to treat cutaneous candidiasis and other skin conditions characterized by fungal infections and inflammation.

How much does nystatin-triamcinolone cream typically cost?

The cost for nystatin-triamcinolone topical cream can range from $30.87 to $31.75 for a 15-gram supply, depending on the pharmacy and location.

What are the key drivers of the triamcinolone market growth?

The broad therapeutic applications, rise in the geriatric population, and development of healthcare infrastructure are key drivers of the triamcinolone market growth.

Which regions are expected to show significant growth in the triamcinolone market?

North America, Europe, and the Asia-Pacific region are expected to show significant growth due to their healthcare infrastructure and population demographics.

Are there any patient assistance programs available for nystatin-triamcinolone cream?

Yes, various patient assistance programs, coupons, and savings cards are available to help patients save up to 90% on their medication costs.

Sources

  1. GMI Insights: Triamcinolone Market 2024 – 2032 Industry Growth Report.
  2. Drugs.com: Nystatin/triamcinolone topical Prices, Coupons, Copay Cards & Patient Assistance.
  3. WICZ: 2031, Nystatin and Triamcinolone Acetonide Market Size 2023.
  4. GlobeNewswire: Triamcinolone Market to Reach $1.3 Billion, Globally, by 2033 at 3.8% CAGR.
  5. NowPatient: nystatin/triamcinolone Coupon, Savings Card and Patient Assistance.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.